Results 171 to 180 of about 237,580 (299)

Editorial: Living Labs (December 2018)

Technology Innovation Management Review, 2018
Chris McPhee, Seppo Leminen, Dimitri Schuurman, Mika Westerlund, Eelko Huizingh   +4 more
doaj   +1 more source

Letter to the Editor on "From Concept to Clinic: Living Labs and Regulatory Sandboxes for Health System Digitalization and the Integration of Innovative Devices Into Clinical Workflows". [PDF]

IEEE J Transl Eng Health Med
Mathias R, Schonfelder A, Welzel C, Gilbert S.   +3 more
europepmc   +1 more source

L'esperienza del Living Lab

, 2018
Buone pratiche di mobility management accademico presso l'Università degli Studi di Bergamo.
openaire   +2 more sources

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Living labs opened dialogues about antibiotic use in dairy cattle and pig sectors - Insights from a Danish case study based on participatory action research. [PDF]

Acta Vet Scand
Vaarst M, Studnitz M, Krogh MA, Kongsted H.   +3 more
europepmc   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

A comprehensive analysis of digital health-focused Living Labs: innovative approaches to dementia. [PDF]

Front Med (Lausanne)
Figueiredo T, Midão L, Carrilho J, Videira Henriques D, Alves S, Duarte N, Bessa MJ, Fidalgo JM, García M, Facal D, Felpete A, Filgueira IR, Carlos Bernárdez J, Rodríguez M, Costa E.   +14 more
europepmc   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Editorial: Living Labs (March 2019)

Technology Innovation Management Review, 2019
Chris McPhee, Anna Ståhlbröst, Abdolrasoul Habibipour, Mari Runardotter, Diana Chronéer   +4 more
doaj   +1 more source

Transforming European Food Systems with multi-actor networks and Living Labs through the FoodSHIFT Approach. [PDF]

Open Res Eur
Schafer LJ, Anthouli A, Schmidt A, Beblek A, Fruehbeisser A, Walthall B, Mingolla C, Rogozan C, Petruzzella D, Wascher D, Volpe F, Ruggeri G, Arciniegas G, Vicente-Vicente JL, Riviou K, Valta K, Marijke Wenzel L, Labellarte L, Crivits M, Swiader M, Lysak M, Sylla M, Eyre P, Barbu R, Corsi S, Henriksen CB.   +25 more
europepmc   +1 more source